Purity Assessment of Protein Preparations

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• Select a purity assessment method by matching sensitivity, throughput, and sample compatibility to the downstream application, not by convenience or habit.
• Validate the chosen method with appropriate controls and calibration standards before trusting quantitative results.
• Every method has blind spots, so orthogonal confirmation with a second technique is required for critical samples.

At a Glance

Selecting a Purity Assessment Method

Protein purity assessment is a foundational step in molecular biology research. The choice of method directly impacts the validity of downstream experiments, from enzymatic assays to structural studies. Researchers must consider the specific requirements of their application, the nature of the protein sample, and the resources available in their laboratory.

Defining Purity in the Context of Your Experiment

Purity is not an absolute property but a relative one. A protein preparation may be considered pure for one application but inadequate for another. For example, a preparation containing a single dominant band on an SDS-PAGE gel may still contain low levels of contaminants that interfere with a sensitive activity assay. Conversely, a preparation with several minor bands may be perfectly suitable for a structural study where the protein of interest is the major species.

The definition of purity must be tied to the experimental question. A researcher studying enzyme kinetics needs to know the exact concentration of the active enzyme. A researcher preparing an antigen for antibody production may tolerate a higher level of contaminating proteins. The assessment method must be chosen to detect the contaminants that matter for the specific application.

Matching Method Sensitivity to Sample Complexity

The sensitivity of the detection method must match the complexity of the sample. A simple two-protein mixture may be adequately assessed by SDS-PAGE. A complex mixture such as a cell lysate requires a more sensitive and specific approach. Mass spectrometry can identify hundreds of proteins in a single sample, providing a comprehensive view of the protein composition.

The choice of method also depends on the abundance of the protein of interest. A highly expressed protein may be easily visualized on a gel. A low-abundance protein may require enrichment or a more sensitive detection method. The researcher must consider the dynamic range of the detection method and the expected concentration of the protein.

Matching Method Throughput to Experimental Scale

Throughput is a practical consideration that affects the feasibility of a purity assessment strategy. A researcher screening many fractions from a purification column needs a rapid method that can process many samples in a short time. A researcher performing a detailed characterization of a single protein may be able to use a slower, more informative method.

The throughput of a method is determined by the time required for sample preparation, the run time, and the data analysis. Some methods, such as UV absorbance, are rapid and can be automated. Others, such as mass spectrometry, require extensive sample preparation and data analysis. The choice of method must balance the need for information with the practical constraints of the laboratory.

Considering Sample Recovery and Destructive Nature

Some purity assessment methods are destructive, meaning they consume the sample. This is an important consideration when the protein is scarce or expensive to produce. Non-destructive methods such as UV absorbance allow the sample to be recovered for further use. Destructive methods such as SDS-PAGE require a separate aliquot of the sample.

The choice between destructive and non-destructive methods depends on the amount of sample available and the need for the sample in downstream experiments. A researcher with a limited amount of protein may choose a non-destructive method for routine checks and reserve a destructive method for final characterization.

Core Principles of Protein Purity Assessment

Protein purity assessment is based on the principle of separating the protein of interest from other components in the sample. The separation can be based on size, charge, hydrophobicity, or a specific binding affinity. The method of detection then determines the amount of the protein and the presence of contaminants.

Separation Based on Molecular Weight

SDS-PAGE separates proteins based on their molecular weight. The protein sample is denatured and coated with a negatively charged detergent, SDS. The proteins then migrate through a polyacrylamide gel in an electric field. The rate of migration is inversely proportional to the logarithm of the molecular weight. The proteins are then visualized by staining with a dye such as Coomassie blue.

The purity of the sample is assessed by the number of bands visible on the gel. A pure sample will show a single band. The presence of multiple bands indicates the presence of contaminating proteins. The sensitivity of the method depends on the staining method and the amount of protein loaded on the gel.

Methods of Separation by Charge

Ion exchange chromatography separates proteins based on their net charge. The protein sample is applied to a column containing a charged resin. Proteins with a charge opposite to the resin bind to the column, while proteins with the same charge pass through. The bound proteins are then eluted with a gradient of increasing salt concentration.

The purity of the sample is determined by the number of peaks in the elution profile. A pure protein will elute as a single peak. The presence of multiple peaks indicates the presence of contaminating proteins. The method is non-destructive and can be used to purify the protein as well as assess its purity.

Methods of Separation Based on Binding Affinity

Affinity chromatography separates proteins based on their specific binding to a ligand. The ligand is attached to a column resin, and the protein sample is passed through the column. The protein of interest binds to the ligand, while other proteins pass through. The bound protein is then eluted with a solution that disrupts the binding.

The purity of the sample is determined by the number of the proteins that bind to the column. A pure protein will bind specifically to the ligand, and the eluted fraction will contain only the protein of interest. The method is highly specific and can be used to purify a protein from a complex mixture.

Practical Workflow for Purity Assessment

A practical workflow for purity assessment involves several steps. The first step is to define the purpose of the assessment. The second step is to select the appropriate method. The third step is to prepare the sample. The fourth step is to perform the assessment. The fifth step is to analyze the results.

Step 1: Define the Purpose of the Assessment

The purpose of the assessment determines the method and the level of detail required. A quick check of the purity of a fraction during a purification may be done with SDS-PAGE. A detailed characterization of the final product may require mass spectrometry. The purpose of the assessment should be written down before the experiment begins.

Step 2: Select the Appropriate Method

The method should be selected based on the purpose of the assessment, the nature of the sample, and the resources available. The method should be able to detect the contaminants that matter for the downstream application. The method should also be compatible with the sample buffer and the protein concentration.

Step 3: Prepare the Sample

The sample must be prepared for the selected method. This may involve diluting the sample, adding a loading buffer, or removing interfering substances. The sample preparation must be consistent between the samples to allow for a comparison. The sample preparation should be documented in the laboratory notebook.

Step 4: Perform the Assessment

The assessment must be performed according to the protocol for the selected method. The protocol must be followed carefully to ensure the results are reliable. The assessment should include appropriate controls, such as a known protein standard and a blank sample.

Step 5: Analyze the Results

The results must be analyzed to determine the purity of the sample. The analysis may involve the visual inspection of a gel, the measurement of a peak area, or the identification of proteins by mass spectrometry. The analysis should be documented and the results should be interpreted in the context of the purpose of the assessment.

Records and Measurements

Accurate records are essential for a reliable purity assessment. The records should include the date of the experiment, the sample identification, the method used, the equipment settings, and the raw data. The records should also include the analysis of the results and the interpretation of the purity.

Recording the Method and Equipment

The method and the equipment used for the assessment must be recorded. The record should include the type of gel, the staining method, the column, the buffer, and the instrument settings. The record should also include the lot number of the reagents and the calibration of the equipment. This information is necessary for the reproducibility of the experiment.

Recording the Sample Information

The sample information must be recorded. This includes the source of the sample, the purification step, the protein concentration, and the buffer composition. The sample information should also include the storage conditions and the number of the freeze-thaw cycles. This information is necessary for the interpretation of the results.

Recording the Results and Analysis

The results of the assessment must be recorded. This includes the image of the gel, the chromatogram, or the mass spectrum. The analysis of the results should also be recorded, including the number of the bands, the peak areas, and the identification of the proteins. The interpretation of the results should be recorded, including the purity of the sample and the presence of the contaminants.

Common Failure Patterns

Several common failure patterns can occur during a purity assessment. These patterns can lead to incorrect conclusions about the purity of the sample. The researcher should be aware of these patterns and take steps to avoid them.

Overloading the Gel

Overloading the gel with too much protein can lead to a poor resolution and the appearance of a smear. The smear can obscure the presence of the contaminating proteins. The amount of protein loaded on the gel should be optimized for the staining method. The optimal amount of protein is typically between 1 and 10 micrograms per lane for Coomassie staining.

Underloading the Gel

Underloading the gel with too little protein can lead to a faint band that is difficult to detect. The faint band may be missed, and the sample may be incorrectly judged to be pure. The amount of protein loaded on the gel should be sufficient for the detection of the protein of interest and the contaminants.

Contamination of the Sample

The sample can be contaminated during the preparation or the analysis. The contamination can come from the reagents, the equipment, or the environment. The contamination can lead to the appearance of the extra bands or the peaks. The researcher should use clean reagents and equipment and work in a clean environment.

Interference from the Buffer

The buffer can interfere with the assessment method. The buffer may contain components that absorb at the same wavelength as the protein, or that interfere with the binding of the dye. The buffer may also contain components that affect the migration of the protein in the gel. The researcher should use a buffer that is compatible with the assessment method.

Quality and Welfare Controls

Quality controls are essential for a reliable purity assessment. The controls should be included in the experiment to ensure that the method is working correctly. The controls should also be used to calibrate the method and to interpret the results.

Positive and Negative Controls

A positive control is a sample that is known to contain the protein of interest. The positive control should be included in the experiment to ensure that the method can detect the protein. A negative control is a sample that is known not to contain the protein of interest. The negative control should be included in the experiment to ensure that the method is specific for the protein.

Calibration Standards

Calibration standards are samples with a known concentration of the protein. The calibration standards should be used to create a standard curve. The standard curve can then be used to determine the concentration of the protein in the unknown sample. The calibration standards should be prepared in the same buffer as the sample.

Replicates and Reproducibility

The experiment should be performed in replicates to ensure the reproducibility of the results. The replicates should be performed on the same sample and on different samples. The replicates should be used to calculate the mean and the standard deviation of the measurements. The reproducibility of the results is a measure of the reliability of the method.

Safety and Regulatory Context

The purity assessment of the protein preparations involves the use of the laboratory equipment and the reagents. The researcher must follow the safety guidelines for the laboratory. The researcher must also be aware of the regulatory requirements for the use of the recombinant or synthetic nucleic acid molecules.

Biosafety Principles

The researcher must follow the biosafety principles for the laboratory. The principles include the risk assessment, the containment, and the institutional oversight. The risk assessment should be performed before the experiment begins. The containment should be appropriate for the risk level of the experiment. The institutional oversight should be provided by the biosafety committee. The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories provides the principles for the biosafety.

Recombinant and Synthetic Nucleic Acid Oversight

The researcher must be aware of the NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. The guidelines provide the oversight for the research involving the recombinant or synthetic nucleic acid molecules. The researcher must follow the guidelines for the experiments that involve the use of the recombinant or synthetic nucleic acid molecules.

Laboratory Safety

The researcher must follow the laboratory safety guidelines for the use of the equipment and the reagents. The guidelines include the use of the personal protective equipment, the proper handling of the chemicals, and the proper disposal of the waste. The researcher must also be aware of the hazards of the equipment, such as the electric shock and the UV radiation.

Professional Escalation Criteria

The researcher should escalate the issue to a supervisor or a specialist if the results of the purity assessment are not consistent with the expectations. The escalation should also occur if the researcher is not able to troubleshoot the problem. The escalation should be documented in the laboratory notebook.

When to Escalate

The researcher should escalate the issue if the purity of the sample is not sufficient for the downstream application. The researcher should also escalate the issue if the method is not working correctly. The researcher should also escalate the issue if the results are not reproducible.

How to Escalate

The researcher should escalate the issue by contacting the supervisor or the specialist. The researcher should provide the supervisor with the records of the experiment, including the method, the data, and the analysis. The researcher should also provide the supervisor with the information about the problem and the steps that have been taken to troubleshoot the problem.

Documentation of the Escalation

The escalation should be documented in the laboratory notebook. The documentation should include the date of the escalation, the person to whom the issue was escalated, and the outcome of the escalation. The documentation should also include the recommendations of the supervisor or the specialist.

Building a Decision Matrix for Purity Method Selection

Choosing a protein purity assessment method is often treated as a matter of personal preference or laboratory habit. This approach leads to mismatched data, wasted samples, and downstream experimental failures. A structured decision matrix removes guesswork by forcing the researcher to score each candidate method against the specific requirements of the experiment. The matrix approach is particularly valuable when multiple researchers share equipment, when a laboratory is establishing a new purification workflow, or when the cost of a failed downstream experiment is high.

Constructing the Decision Matrix

The decision matrix begins with a list of candidate methods appropriate for the sample type and laboratory resources. For most protein purification workflows, the candidate list includes SDS-PAGE with Coomassie staining, Western blot, size exclusion chromatography, mass spectrometry, and UV absorbance. Each method is then scored against a set of weighted criteria that reflect the needs of the specific experiment.

The criteria should be selected before any scoring begins. Common criteria include sensitivity, throughput, sample recovery, cost per sample, technical expertise required, and compatibility with the sample buffer. The weights assigned to each criterion must reflect the priorities of the downstream application. A researcher preparing a protein for structural studies by X-ray crystallography would weight sample recovery and sensitivity heavily. A researcher screening hundreds of fractions from a purification column would weight throughput and cost more heavily.

The scoring scale should be simple and consistent. A five point scale where one is poor and five is excellent works well for most applications. The score for each method is multiplied by the weight of each criterion, and the products are summed to give a total score for each method. The method with the highest total score is the most appropriate for the stated purpose.

Worked Example of the Matrix

Consider a researcher who needs to assess the purity of a recombinant enzyme after affinity chromatography. The enzyme will be used in a kinetic assay where contaminating proteases could degrade the substrate and produce false results. The researcher has access to SDS-PAGE, UV spectroscopy, and mass spectrometry through a core facility.

The criteria and weights are as follows. Sensitivity to low abundance contaminants receives a weight of five because the kinetic assay is sensitive to trace proteases. Throughput receives a weight of two because only a few fractions need to be checked. Sample recovery receives a weight of three because the enzyme is produced in limited quantity. Cost receives a weight of two because the researcher has a limited budget. Technical expertise receives a weight of three because the researcher is comfortable with routine methods but has limited mass spectrometry experience.

SDS-PAGE with Coomassie staining scores three for sensitivity, four for throughput, one for sample recovery, five for cost, and five for technical expertise. The weighted score is calculated as follows. Sensitivity contributes 30 multiplied by three equals 90. Throughput contributes two multiplied by four equals eight. Sample recovery contributes three multiplied by one equals three. Cost contributes two multiplied by five equals ten. Technical expertise contributes three multiplied by five equals fifteen. The total score is 126.

UV absorbance scores one for sensitivity, five for throughput, five for sample recovery, five for cost, and five for technical expertise. The weighted score is 30 multiplied by one equals 30 for sensitivity. Throughput is two multiplied by five equals ten. Sample recovery is three multiplied by five equals fifteen. Cost is two multiplied by five equals ten. Technical expertise is three multiplied by five equals fifteen. The total score is 80.

Mass spectrometry scores five for sensitivity, one for throughput, one for sample recovery, one for cost, and two for technical expertise. The weighted score is 30 multiplied by five equals 150 for sensitivity. Throughput is two multiplied by one equals two. Sample recovery is three multiplied by one equals three. Cost is two multiplied by one equals two. Technical expertise is three multiplied by two equals six. The total score is 163.

The matrix indicates that mass spectrometry is the most appropriate method for this experiment because the sensitivity requirement outweighs the cost and throughput limitations. The researcher should then plan to use mass spectrometry for the final purity assessment and reserve SDS-PAGE for the routine fraction checks during the purification.

Adjusting the Matrix for Different Applications

The matrix must be adjusted when the downstream application changes. A researcher preparing an antigen for antibody production may not need to detect low abundance contaminants. The sensitivity weight would be reduced and the throughput weight would be increased. The matrix would then favor SDS-PAGE or UV absorbance.

A researcher working with a membrane protein that is difficult to keep in solution will need to weight sample recovery and buffer compatibility heavily. The matrix would favor a non-destructive method such as size exclusion chromatography or UV absorbance. The researcher must also consider whether the method can be performed in the presence of the detergents required to keep the membrane protein soluble.

A researcher working with a protein that has no aromatic residues will find that UV absorbance at 280 nm is not useful. The matrix should include a criterion for the compatibility of the detection method with the protein sequence. The researcher should then consider alternative detection methods such as the Bradford assay or a specific activity assay.

Implementing the Matrix in a Laboratory Setting

The decision matrix should be documented and shared with the laboratory members. The matrix can be created in a spreadsheet program and stored in a shared laboratory folder. The matrix should be reviewed and updated when new methods become available or when the laboratory acquires new equipment.

The matrix should be used at the beginning of a new project and whenever the downstream application changes. The matrix should also be used when a purity assessment method fails to provide the required information. The matrix can help the researcher identify an alternative method that better matches the requirements.

The matrix should be included in the laboratory notebook for each purification project. The matrix provides a record of the decision making process and can be used to justify the choice of method in a publication or a thesis. The matrix also provides a basis for troubleshooting when the purity assessment results are not consistent with the expectations.

Common Mistakes in Using the Matrix

The most common mistake is assigning weights that do not reflect the actual requirements of the downstream application. The researcher must be honest about the sensitivity and throughput requirements. The researcher must also consider the cost of the downstream experiment. A failed kinetic assay due to a contaminating protease is more expensive than the cost of a mass spectrometry analysis.

The second common mistake is using the matrix to justify a method that the researcher is already comfortable with. The matrix must be used objectively. The researcher should score each method based on the actual performance and not on the familiarity with the method.

The third common mistake is not updating the matrix when the laboratory acquires new equipment or when the sample type changes. The matrix is a living document that must be reviewed regularly. The matrix should be updated when the researcher learns a new technique or when the laboratory changes its standard protocols.

The Matrix as a Troubleshooting Tool

The matrix can also be used to troubleshoot a purity assessment that is not working correctly. If the SDS-PAGE shows a smear instead of a distinct band, the researcher can use the matrix to identify an alternative method that may be more suitable for the sample. The matrix can also be used to identify the criteria that are not being met by the current method.

For example, if the SDS-PAGE is not sensitive enough to detect a low abundance contaminant, the matrix will show that the sensitivity weight is high and that the SDS-PAGE score is low. The researcher can then switch to a more sensitive method such as mass spectrometry or Western blot. The matrix provides a systematic way to identify the best alternative method.

The matrix can also be used to identify the need for a second method. If the matrix shows that no single method meets all the criteria, the researcher should consider using two methods in combination. For example, the researcher may use SDS-PAGE for the routine fraction checks and mass spectrometry for the final purity assessment. The matrix can be used to plan the combination of methods.

The Matrix and the Quality Control Program

The decision matrix should be part of the laboratory quality control program. The matrix provides a documented basis for the choice of the purity assessment method. The matrix should be reviewed by the laboratory supervisor or the quality assurance officer. The matrix should be updated when the laboratory changes its standard protocols.

The matrix should also be used to train new laboratory members. The new researcher can use the matrix to understand why a particular method is used for a particular application. The matrix provides a clear and objective basis for the method selection. The matrix should be included in the laboratory training manual.

The matrix should be used to evaluate the performance of the purity assessment methods over time. The laboratory should track the success rate of the purity assessments and the number of the failed experiments. The matrix should be updated to reflect the performance of the methods. The matrix should be used to identify the methods that are not performing well and to replace them with the more reliable methods.

The Matrix and the Downstream Application

The matrix is only useful if it is tied to the downstream application. The researcher must clearly define the requirements of the downstream application before the matrix is constructed. The researcher must also consider the consequences of a purity assessment error. A purity assessment error can lead to a failed experiment, a wasted sample, and a wasted time.

The matrix should be used to select the method that minimizes the risk of a purity assessment error. The matrix should also be used to select the method that provides the most information for the downstream application. The matrix should be used to select the method that is the most cost effective for the laboratory.

The matrix should be used to communicate the purity assessment strategy to the collaborators and the funding agencies. The matrix provides a clear and objective justification for the choice of the method. The matrix should be included in the grant proposal and the progress report. The matrix should be used to demonstrate that the laboratory has a rigorous approach to the quality control.

The Matrix and the Regulatory Context

The matrix should be used in the context of the laboratory quality standards. The NIST Laboratory Programs provide the measurement science and the standards for the quality. The matrix should be used to ensure that the purity assessment methods are calibrated and the results are reliable. The matrix should be used to ensure that the laboratory is using the best available methods.

The matrix should also be used in the context of the biosafety and the regulatory requirements. The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories provides the principles for the biosafety. The matrix should be used to ensure that the purity assessment is performed in a safe manner. The matrix should be used to ensure that the laboratory is compliant with the institutional oversight.

The matrix should be used in the context of the NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. The matrix should be used to ensure that the purity assessment is performed in a manner that is consistent with the guidelines. The matrix should be used to ensure that the laboratory is compliant with the requirements for the research involving the recombinant or synthetic nucleic acid molecules.

The Matrix and the Professional Escalation

The matrix should be used to identify the situations where the professional escalation is required. If the matrix shows that no method is available to meet the requirements of the downstream application, the researcher should escalate the issue to the supervisor or the specialist. The matrix should be used to document the need for the escalation.

The matrix should also be used to identify the situations where the purity assessment is not working correctly. If the matrix shows that the method is not meeting the criteria, the researcher should escalate the issue. The matrix should be used to document the problem and the steps that have been taken to troubleshoot the problem.

The matrix should be used to communicate the problem to the supervisor or the specialist. The matrix provides a clear and objective summary of the situation. The matrix should be included in the escalation documentation. The matrix should be used to the supervisor or the specialist to understand the problem and to provide the recommendations.

The Matrix and the Laboratory Notebook

The matrix should be recorded in the laboratory notebook for each purification project. The matrix should include the date, the sample identification, the criteria, the weights, the scores, and the total scores. The matrix should also include the rationale for the choice of the criteria and the weights. The matrix should be used to document the decision making process.

The matrix should be updated when the project progresses. The matrix should be updated when the new information is available. The matrix should be updated when the downstream application changes. The matrix should be used to track the changes in the decision making process.

The matrix should be used to the final report of the purification project. The matrix should be included in the report to demonstrate the rationale for the choice of the method. The matrix should be used to the report to the laboratory and the funding. The matrix should be used to the report to the scientific community.

The Matrix and the Future of the Purity Assessment

The matrix is a flexible tool that can be adapted to the new methods and the new technologies. The matrix should be updated when the new methods are developed. The matrix should be used to evaluate the new methods and to the laboratory to adopt the new methods. The matrix should be used to the laboratory to stay current with the best practices.

The matrix should be used to the laboratory to develop the standard operating procedures for the purity assessment. The matrix should be used to the laboratory to ensure that the purity assessment is performed in a consistent manner. The matrix should be used to the laboratory to ensure that the purity assessment is reliable and the results are reproducible.

The matrix should be used to the laboratory to train the new researchers. The matrix should be used to the new researchers to understand the decision making process. The matrix should be used to the new researchers to learn the best practices for the purity assessment. The matrix should be used to the laboratory to build a culture of the quality and the rigor.

Frequently Asked Questions

What is the most common method for assessing protein purity?

SDS-PAGE with Coomassie staining is the most common method for assessing protein purity. The method is simple, inexpensive, and can be used to assess the purity of a protein sample. The method is based on the separation of the proteins by their molecular weight.

How do I choose between SDS-PAGE and mass spectrometry for purity assessment?

The choice between SDS-PAGE and mass spectrometry depends on the purpose of the assessment. SDS-PAGE is a simple and rapid method that can be used for a quick check of the purity. Mass spectrometry is a more sensitive and comprehensive method that can be used for a detailed characterization of the protein. The choice should be based on the sensitivity and the information required.

Can I use UV absorbance to assess protein purity?

UV absorbance at 280 nm can be used to estimate the protein concentration, but it is not a reliable method for assessing purity. The absorbance at 280 nm is due to the aromatic amino acids, and the contaminants can also absorb at this wavelength. The purity of the protein should be assessed by a method that can separate the protein from the contaminants.

What is the limit of detection for Coomassie staining?

The limit of detection for Coomassie staining is typically in the range of 10 to 100 nanograms of protein per band. The limit of detection depends on the staining method and the protein. The limit of detection can be improved by using a more sensitive staining method, such as silver staining.

How can I improve the sensitivity of my purity assessment?

The sensitivity of the purity assessment can be improved by using a more sensitive detection method. The sensitivity can also be improved by increasing the amount of protein loaded on the gel or by concentrating the sample. The sensitivity can also be improved by using a more specific detection method, such as Western blotting.

What is the role of the controls in a purity assessment?

The controls are essential for a reliable purity assessment. The positive control ensures that the method can detect the protein of interest. The negative control ensures that the method is specific for the protein. The calibration standards are used to create a standard curve for the quantification of the protein.

How do I document the results of a purity assessment?

The results of the purity assessment should be documented in the laboratory notebook. The documentation should include the date of the experiment, the sample used, the method, the equipment, and the results. The documentation should also include the analysis of the results and the interpretation of the purity.

What should I do if the purity of my protein is not sufficient?

If the purity of the protein is not sufficient, the researcher should troubleshoot the problem. The researcher should check the purification protocol and the assessment method. The researcher should also consider the use of an additional purification step. If the problem cannot be resolved, the researcher should escalate the issue to a supervisor or a specialist.

Using the Evidence

Related Molecular Biology Guides

• Protein Quality Assessment: Methods and Applications
• Intact Protein Mass Spectrometry: Principles and Applications
• Automated Protein Quantification: Methods and Applications
• Protein Crystallization: Principles, Methods, and Applications
• Protein Quantification Mass Spectrometry: A Practical Guide

References and Further Reading

• Molecular Biology and Laboratory Methods. National Library of Medicine.
• Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
• NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
• Addgene Protocols. Addgene.
• MIQE Guidelines. Clinical Chemistry.
• NIST Laboratory Programs. National Institute of Standards and Technology.
• Effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity.. BioTechniques, 1997.
• Methods for the Determination of the Purity of Exosomes.. Current pharmaceutical design, 2019.
• Protein decomplexation and proteomics: A complementary assessment method of the physicochemical purity of antivenom.. Biologicals : journal of the International Association of Biological Standardization, 2021.
• Assessment of snake antivenom purity by comparing physicochemical and immunochemical methods.. Biologicals : journal of the International Association of Biological Standardization, 2013.
• Determination of protein purity.. Methods in enzymology, 2009.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.